DHX34 and acute myeloid leukemia: It was recently shown that DHX34 is subject to widespread alternative splicing in sporadic AML, resulting in the inclusion of alternative exon 12b that harbors a PTC, leading to Alternative splicing coupled to NMD (AS-NMD) (Fig. 5A; Rivera et al. 2021).